Category

Private Markets

Top 10 Highlights from the APAC PE, VC and Startup Ecosystem this Week – 14 Jul 2024

By | Private Markets, Smartkarma Newswire

Top ten highlights from the APAC PE, VC, and startup ecosystem this week:

  1. Temasek Holdings plans to increase investments in India while monitoring policies in China, following a positive turnaround in shareholder returns.
  2. Indonesia Investment Authority doubles investments, leading to a significant increase in total assets under management.
  3. Zephyr Peacock may undergo top management reshuffle impacting the timeline for its fourth India-focused fund.
  4. HongShan closes a new fund to support companies in technology, healthcare, and consumer sectors.
  5. Hahn & Co surpasses fundraising target, becoming the largest single country-focused fund in Asia.
  6. B Capital seeks new funds for growth, healthcare, and climate investments.
  7. Atinum Investment to focus more on Southeast Asia after closing its flagship global fund.
  8. M Venture Partners and TNB Aura looking to raise fresh funds for investments in the region.
  9. LongRiver Investments raises inaugural USD fund for healthcare and technology sectors.
  10. Glory Ventures in the market for its third USD-denominated fund, with Isola Capital securing anchor investors for its latest fund.

APAC Private Markets Research

Explore latest Insights on APAC Private Markets on Smartkarma


Disclaimer:This article by is general in nature and based on publicly available information and not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material. While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars

Also, check out the latest in ECM Research on Smartkarma